The best indicator for NXP Semiconductors (NXPI)
We backtested 20 indicators across daily, weekly and hourly charts on real NXP Semiconductors (NXPI) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Holy Grail Confluence
On the daily chart, this is the strongest risk-adjusted edge we found for NXP Semiconductors (NXPI) over ~15.8 years — trailing buy-and-hold by 8.8% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Rate of Change | Weekly | 18.8% | 0.74 | -53.0% | 42.0% | 50 | -3.3% |
| 2 | Holy Grail Confluence ✓ | Daily | 13.4% | 0.61 | -54.9% | 72.0% | 25 | -8.8% |
| 3 | EMA 20/50 Cross | Daily | 13.5% | 0.57 | -50.4% | 51.6% | 31 | -8.8% |
| 4 | Williams %R ✓ | Weekly | 11.5% | 0.54 | -48.7% | 76.2% | 21 | -10.6% |
| 5 | Heikin-Ashi Trend ✓ | Weekly | 12.0% | 0.54 | -43.0% | 50.0% | 144 | -10.1% |
| 6 | Stochastic ✓ | Daily | 9.6% | 0.47 | -47.2% | 77.2% | 79 | -12.7% |
| 7 | CCI ✓ | Daily | 9.9% | 0.47 | -54.8% | 72.3% | 83 | -12.4% |
| 8 | WaveTrend (8/6/4) ✓ | Daily | 10.1% | 0.47 | -56.3% | 63.6% | 55 | -12.1% |
| 9 | Stochastic ✓ | Weekly | 9.5% | 0.47 | -48.7% | 68.8% | 16 | -12.6% |
| 10 | Donchian Midline | Weekly | 9.3% | 0.45 | -46.0% | 48.7% | 39 | -12.8% |
| 11 | Bollinger Mean-Reversion ✓ | Daily | 8.2% | 0.44 | -50.5% | 72.6% | 62 | -14.0% |
| 12 | EMA-10 Trend | Weekly | 8.2% | 0.42 | -60.4% | 46.4% | 69 | -13.8% |
| 13 | Williams %R ✓ | Daily | 8.1% | 0.41 | -48.9% | 72.9% | 107 | -14.2% |
| 14 | MACD | Weekly | 5.5% | 0.34 | -51.4% | 37.8% | 37 | -16.6% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For NXP Semiconductors (NXPI), Holy Grail Confluence on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.